
Sign up to save your podcasts
Or


Many people are worried that their favorite deodorant is going to cause them an early death, but when it comes down to it, we're more worried that we're going to smell like death. This conundrum perfectly articulates the juggling act between the short term benefit and long term risk with skin care products. In an ideal world, regulators would keep us from harm's way. In the real world, long-term cancer risk, hormone disruption, and even organ damage are difficult to track and quantify so this is an evolving discussion. On this week's podcast, you'll meet the CEO of a testing company focused on safety and efficacy for manufacturers.
Listen and learn:
Links
dermatest.com
ABOUT OUR GUEST
Marcel Voss is the CEO of Dermatest GmbH, a company that specializes in skin testing and analysis.
Like the Show?
By Lucas Rockwood4.8
928928 ratings
Many people are worried that their favorite deodorant is going to cause them an early death, but when it comes down to it, we're more worried that we're going to smell like death. This conundrum perfectly articulates the juggling act between the short term benefit and long term risk with skin care products. In an ideal world, regulators would keep us from harm's way. In the real world, long-term cancer risk, hormone disruption, and even organ damage are difficult to track and quantify so this is an evolving discussion. On this week's podcast, you'll meet the CEO of a testing company focused on safety and efficacy for manufacturers.
Listen and learn:
Links
dermatest.com
ABOUT OUR GUEST
Marcel Voss is the CEO of Dermatest GmbH, a company that specializes in skin testing and analysis.
Like the Show?

570 Listeners

3,281 Listeners

1,104 Listeners

1,247 Listeners

12,725 Listeners

2,508 Listeners

2,054 Listeners

3,825 Listeners

3,511 Listeners

9,211 Listeners

8,603 Listeners

603 Listeners

1,342 Listeners

29,178 Listeners

1,197 Listeners